gsk and Dr Reddys do have connections. I can't imagine gsk ruining their Arixtra market by offering the generic at a really low price. I wouldn't be surprised if there's a bit of a gentlemans agreement here, a bit like Qantas and Virgin Blue used to offer the same fares.
Remember too that Bioshares once suggest acl might make Arixtra for GSK. Maybe a deal will be done where they supply all three. A $10m upfront payment and we can start HyACTing!
The other senario is a takeover offer, which can't be far off if it's going to happen.
- Forums
- ASX - By Stock
- TSN
- sales imminent article .profitable in 2011 ?
sales imminent article .profitable in 2011 ?, page-35
Featured News
Add TSN (ASX) to my watchlist
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable